AGRE to Provide Autism Data through BioDiscovery Platform in Co-marketing Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Bioinformatics firm BioDiscovery and the Autism Genetic Resource Exchange today announced a co-marketing agreement that allows AGRE to provide copy number and allelic event data to its researchers through BioDiscovery's Nexus DB platform.

BioDiscovery's platform is for DNA copy number analysis and integrates and processes data from commercial array platforms as well as custom arrays. AGRE, a program of Autism Speaks, collects and houses genetic and phenotypic data on more than 1,300 families with autism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.